Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension

Erica A. Wehrwein, Martin Novotny, Greg M. Swain, Lindsay M. Parker, Mohammad Esfahanian, John M. Spitsbergen, Beth Habecker, David L. Kreulen

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Uptake of norepinephrine via the neuronal norepinephrine transporter is reduced in the heart during deoxycorticosterone (DOCA)-salt hypertension. We hypothesized that this was due to reduced norepinephrine transporter mRNA and/or protein expression in the stellate ganglia and heart. After 4. weeks of DOCA-salt treatment there was no change in norepinephrine transporter mRNA in either the right or the left stellate ganglia from hypertensive rats (n = 5-7, p > 0.05). Norepinephrine transporter immunoreactivity in the left stellate ganglion was significantly increased (n = 4, p. <0.05) while the right stellate ganglion was unchanged (n = 4, p > 0.05). Whole heart norepinephrine content was significantly reduced in DOCA rats consistent with reduced uptake function; however, when norepinephrine was assessed by chamber, a significant decrease was noted only in the right atrium and right ventricle (n = 6, p <0.05). Cardiac norepinephrine transport binding by chamber revealed that it was only reduced in the left atrium (n = 5-7, p > 0.05). Therefore, 1) contrary to our hypothesis reduced reuptake in the hypertensive heart is not exclusively due to an overall reduction in norepinephrine transporter mRNA or protein in the stellate ganglion or heart, and 2) norepinephrine transporter regulation occurs regionally in the heart and stellate ganglion in the hypertensive rat heart.

Original languageEnglish (US)
Pages (from-to)99-107
Number of pages9
JournalAutonomic Neuroscience: Basic and Clinical
Volume179
Issue number1-2
DOIs
StatePublished - 2013

Fingerprint

Norepinephrine Plasma Membrane Transport Proteins
Desoxycorticosterone Acetate
Stellate Ganglion
Salts
Hypertension
Norepinephrine
Messenger RNA
Desoxycorticosterone
Heart Atria
Heart Ventricles
Proteins

Keywords

  • Cardiac
  • Hypertension
  • NAT
  • NET
  • Noradrenaline
  • Stellate ganglion

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Endocrine and Autonomic Systems

Cite this

Wehrwein, E. A., Novotny, M., Swain, G. M., Parker, L. M., Esfahanian, M., Spitsbergen, J. M., ... Kreulen, D. L. (2013). Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension. Autonomic Neuroscience: Basic and Clinical, 179(1-2), 99-107. https://doi.org/10.1016/j.autneu.2013.08.070

Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension. / Wehrwein, Erica A.; Novotny, Martin; Swain, Greg M.; Parker, Lindsay M.; Esfahanian, Mohammad; Spitsbergen, John M.; Habecker, Beth; Kreulen, David L.

In: Autonomic Neuroscience: Basic and Clinical, Vol. 179, No. 1-2, 2013, p. 99-107.

Research output: Contribution to journalArticle

Wehrwein, EA, Novotny, M, Swain, GM, Parker, LM, Esfahanian, M, Spitsbergen, JM, Habecker, B & Kreulen, DL 2013, 'Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension', Autonomic Neuroscience: Basic and Clinical, vol. 179, no. 1-2, pp. 99-107. https://doi.org/10.1016/j.autneu.2013.08.070
Wehrwein, Erica A. ; Novotny, Martin ; Swain, Greg M. ; Parker, Lindsay M. ; Esfahanian, Mohammad ; Spitsbergen, John M. ; Habecker, Beth ; Kreulen, David L. / Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension. In: Autonomic Neuroscience: Basic and Clinical. 2013 ; Vol. 179, No. 1-2. pp. 99-107.
@article{379324183d454013924e9e45631cff03,
title = "Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension",
abstract = "Uptake of norepinephrine via the neuronal norepinephrine transporter is reduced in the heart during deoxycorticosterone (DOCA)-salt hypertension. We hypothesized that this was due to reduced norepinephrine transporter mRNA and/or protein expression in the stellate ganglia and heart. After 4. weeks of DOCA-salt treatment there was no change in norepinephrine transporter mRNA in either the right or the left stellate ganglia from hypertensive rats (n = 5-7, p > 0.05). Norepinephrine transporter immunoreactivity in the left stellate ganglion was significantly increased (n = 4, p. <0.05) while the right stellate ganglion was unchanged (n = 4, p > 0.05). Whole heart norepinephrine content was significantly reduced in DOCA rats consistent with reduced uptake function; however, when norepinephrine was assessed by chamber, a significant decrease was noted only in the right atrium and right ventricle (n = 6, p <0.05). Cardiac norepinephrine transport binding by chamber revealed that it was only reduced in the left atrium (n = 5-7, p > 0.05). Therefore, 1) contrary to our hypothesis reduced reuptake in the hypertensive heart is not exclusively due to an overall reduction in norepinephrine transporter mRNA or protein in the stellate ganglion or heart, and 2) norepinephrine transporter regulation occurs regionally in the heart and stellate ganglion in the hypertensive rat heart.",
keywords = "Cardiac, Hypertension, NAT, NET, Noradrenaline, Stellate ganglion",
author = "Wehrwein, {Erica A.} and Martin Novotny and Swain, {Greg M.} and Parker, {Lindsay M.} and Mohammad Esfahanian and Spitsbergen, {John M.} and Beth Habecker and Kreulen, {David L.}",
year = "2013",
doi = "10.1016/j.autneu.2013.08.070",
language = "English (US)",
volume = "179",
pages = "99--107",
journal = "Autonomic Neuroscience: Basic and Clinical",
issn = "1566-0702",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension

AU - Wehrwein, Erica A.

AU - Novotny, Martin

AU - Swain, Greg M.

AU - Parker, Lindsay M.

AU - Esfahanian, Mohammad

AU - Spitsbergen, John M.

AU - Habecker, Beth

AU - Kreulen, David L.

PY - 2013

Y1 - 2013

N2 - Uptake of norepinephrine via the neuronal norepinephrine transporter is reduced in the heart during deoxycorticosterone (DOCA)-salt hypertension. We hypothesized that this was due to reduced norepinephrine transporter mRNA and/or protein expression in the stellate ganglia and heart. After 4. weeks of DOCA-salt treatment there was no change in norepinephrine transporter mRNA in either the right or the left stellate ganglia from hypertensive rats (n = 5-7, p > 0.05). Norepinephrine transporter immunoreactivity in the left stellate ganglion was significantly increased (n = 4, p. <0.05) while the right stellate ganglion was unchanged (n = 4, p > 0.05). Whole heart norepinephrine content was significantly reduced in DOCA rats consistent with reduced uptake function; however, when norepinephrine was assessed by chamber, a significant decrease was noted only in the right atrium and right ventricle (n = 6, p <0.05). Cardiac norepinephrine transport binding by chamber revealed that it was only reduced in the left atrium (n = 5-7, p > 0.05). Therefore, 1) contrary to our hypothesis reduced reuptake in the hypertensive heart is not exclusively due to an overall reduction in norepinephrine transporter mRNA or protein in the stellate ganglion or heart, and 2) norepinephrine transporter regulation occurs regionally in the heart and stellate ganglion in the hypertensive rat heart.

AB - Uptake of norepinephrine via the neuronal norepinephrine transporter is reduced in the heart during deoxycorticosterone (DOCA)-salt hypertension. We hypothesized that this was due to reduced norepinephrine transporter mRNA and/or protein expression in the stellate ganglia and heart. After 4. weeks of DOCA-salt treatment there was no change in norepinephrine transporter mRNA in either the right or the left stellate ganglia from hypertensive rats (n = 5-7, p > 0.05). Norepinephrine transporter immunoreactivity in the left stellate ganglion was significantly increased (n = 4, p. <0.05) while the right stellate ganglion was unchanged (n = 4, p > 0.05). Whole heart norepinephrine content was significantly reduced in DOCA rats consistent with reduced uptake function; however, when norepinephrine was assessed by chamber, a significant decrease was noted only in the right atrium and right ventricle (n = 6, p <0.05). Cardiac norepinephrine transport binding by chamber revealed that it was only reduced in the left atrium (n = 5-7, p > 0.05). Therefore, 1) contrary to our hypothesis reduced reuptake in the hypertensive heart is not exclusively due to an overall reduction in norepinephrine transporter mRNA or protein in the stellate ganglion or heart, and 2) norepinephrine transporter regulation occurs regionally in the heart and stellate ganglion in the hypertensive rat heart.

KW - Cardiac

KW - Hypertension

KW - NAT

KW - NET

KW - Noradrenaline

KW - Stellate ganglion

UR - http://www.scopus.com/inward/record.url?scp=84893907141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893907141&partnerID=8YFLogxK

U2 - 10.1016/j.autneu.2013.08.070

DO - 10.1016/j.autneu.2013.08.070

M3 - Article

C2 - 24075956

AN - SCOPUS:84893907141

VL - 179

SP - 99

EP - 107

JO - Autonomic Neuroscience: Basic and Clinical

JF - Autonomic Neuroscience: Basic and Clinical

SN - 1566-0702

IS - 1-2

ER -